Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Trazzi

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Biological Engineering|July 17, 2025
Lactic acid bacteria as microbial cell factories for the in vivo delivery of therapeutic proteins as secretable TAT fusion productsGiorgio Medici, Giulia Candini, Nicola Mottolese, et al.
European Journal of Medicinal Chemistry|June 20, 2025
Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer's diseasePedro de Sena M Pinheiro, Francesca de Chirico, Manuela Loi, et al.
International Journal of Molecular Sciences|March 29, 2023
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency DisorderManuela Loi, Stefano Bastianini, Giulia Candini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 3, 2025
Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiencyGiorgio Medici, Marianna Tassinari, Manuela Loi, et al.
Aging and Disease|June 7, 2021
Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and DeathLaura Gennaccaro, Claudia Fuchs, Manuela Loi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 15, 2022
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency DisorderGiorgio Medici, Marianna Tassinari, Giuseppe Galvani, et al.
European Journal of Medicinal Chemistry|June 15, 2025
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's diseaseAlan Santini, Elisa Tassinari, Alessandra Altomare, et al.
ACS Chemical Neuroscience|May 15, 2024
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's DiseaseAlan Santini, Elisa Tassinari, Eleonora Poeta, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Biological Engineering|July 17, 2025
Lactic acid bacteria as microbial cell factories for the in vivo delivery of therapeutic proteins as secretable TAT fusion productsGiorgio Medici, Giulia Candini, Nicola Mottolese, et al.
European Journal of Medicinal Chemistry|June 20, 2025
Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer's diseasePedro de Sena M Pinheiro, Francesca de Chirico, Manuela Loi, et al.
International Journal of Molecular Sciences|March 29, 2023
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency DisorderManuela Loi, Stefano Bastianini, Giulia Candini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 3, 2025
Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiencyGiorgio Medici, Marianna Tassinari, Manuela Loi, et al.
Aging and Disease|June 7, 2021
Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and DeathLaura Gennaccaro, Claudia Fuchs, Manuela Loi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 15, 2022
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency DisorderGiorgio Medici, Marianna Tassinari, Giuseppe Galvani, et al.
European Journal of Medicinal Chemistry|June 15, 2025
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's diseaseAlan Santini, Elisa Tassinari, Alessandra Altomare, et al.
ACS Chemical Neuroscience|May 15, 2024
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's DiseaseAlan Santini, Elisa Tassinari, Eleonora Poeta, et al.
Pageof 5